This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Laven, D. L. Articles by Shaw, S. M. Search for Related Content Social Bookmarking                         What's this?

Detection of Drug Interactions Involving Radiopharmaceuticals: A Professional Responsibility of the Clinical Pharmacist

Nuclear Pharmacy, PO Box 636, VA Medical Center, Bay Pines, FL 33504-0636

Stanley M. Shaw

Nuclear Pharmacy, PO Box 636, VA Medical Center, Bay Pines, FL 33504-0636

Radiopharmaceuticals are radioactive drugs used in nuclear medicine for diagnosis and, to some degree, for the treatment of disease. Considerable evidence exists in regard to the potential for altered biorouting of radiopharmaceuticals resulting from the coadministration of therapeutic drugs, as well as from certain disease states, nutritional conditions, and other factors. Altered biorouting may reduce the usefulness of the diagnostic test or provide misleading information. While retrospective identification of an altered biodistribution problem can be helpful, prospective detection is more desirable and can be achieved by a hospital-based pharmacist. Although most drug-radiopharmaceutical interactions are not beneficial, some nuclear medicine procedures are conducted using drug intervention to enhance the diagnostic efficacy of the test. Also, nuclear medicine procedures may be used to monitor the outcome of a therapeutic regimen or to aid in determining the pharmacologic effect of an investigation drug. While not covering the full scope of the area, the material in this chapter is intended to provide an introduction to the problems and opportunities associated with drug-radiopharmaceutical interactions and to stimulate pharmacists to provide clinical pharmacy services to nuclear medicine.

Journal of Pharmacy Practice, Vol. 2, No. 5, 287-298 (1989)
DOI: 10.1177/089719008900200506


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?